TY - JOUR T1 - Flattening Filter Free <em>vs</em>. Flattened Beams for Lung Stereotactic Body Radiation Therapy JF - Anticancer Research JO - Anticancer Res SP - 5133 LP - 5139 VL - 37 IS - 9 AU - PIERRE ANNEDE AU - JULIEN DARREON AU - AHCENE BENKEMOUCHE AU - SIMON VALDENAIRE AU - MARGUERITE TYRAN AU - BERTRAND KAEPPELIN AU - ALBAN MACAGNO AU - JULIEN BARROU AU - LEONEL VARELA CAGETTI AU - VERONIQUE FAVREL AU - LAURENCE MOUREAU-ZABOTTO AU - LAURENCE GONZAGUE AU - PIERRE FAU AU - CYRUS CHARGARI AU - AGNES TALLET AU - NAJI SALEM Y1 - 2017/09/01 UR - http://ar.iiarjournals.org/content/37/9/5133.abstract N2 - Background/Aim: To assess the clinical impact of high dose rate stereotactic body radiation therapy (SBRT) in patients with lung neoplastic lesions. Patients and Methods: From January 2014 to June 2016, a single-center retrospective analysis was performed including all patients treated by either flattening filter free (FFF) beams or flattening filter beams (FF) three-dimensional (3D) SBRT for lung neoplastic lesions. Results: A total of 99 SBRT were performed on 75 patients. Among these, 29 SBRT were performed using a FFF technique while 70 other SBRT were done using a FF technique. Median follow-up time was 12.9 months. Overall, no difference between the two groups was found except for the mean beam on time which was reduced by 3.3 to 0.9 minutes in the FFF group (p&lt;0.001). Conclusion: We report a low toxicity rate and a shortened beam on time in patients treated with 3D FFF SBRT for lung neoplastic lesions. ER -